Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03191084 · ClinicalTrials.gov registry record · Early Phase 1
Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations
A Early Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 26
- Enrollment target
NCT03191084 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 26 participants.
The verdict
NCT03191084, a Early Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
Marijuana is one of the most widely used substances. This study will characterize the persistence of cannabis' (CNB's) acute effects on cognitive test performance and simulated driving over a several hour time period. The data obtained from simulated driving, cognitive tests, and biological assays of THC will be used in analyses aimed at identifying what tests or combination of tests predict both recent use and driving impairment risk. Eligible participants will undergo a full day screening visit, if still eligible they will come to Hartford Hospital in Hartford, Connecticut to take part in the full study. Participation requires overnight stays between each of the five study visits. On each of the study days participants are dosed with either a low dose of THC marijuana, a high dose of THC marijuana or placebo marijuana, (the low and high doses are repeated once each, order in which the study drug is given is double blind and chosen at random.)
Interventions
- DRUG Low Dose THC Marijuana
- DRUG High Dose THC Marijuana
- DRUG Placebo Marijuana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2020-03-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03191084
The ClinicalTrials.gov registry entry for NCT03191084 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Low Dose THC Marijuana is the first listed.
NCT03191084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03191084 about?
NCT03191084 is a clinical study titled "Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations". Marijuana is one of the most widely used substances. This study will characterize the persistence of cannabis' (CNB's) acute effects on cognitive test performance and simulated driving over a several hour time period. The data obtained from simulated driving, cognitive tests, and biological assays o...
What is the current status of trial NCT03191084?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 26 participants. The study started on 2017-12-01. Estimated completion is 2020-03-30.
What interventions are being tested in trial NCT03191084?
The interventions under investigation include: Low Dose THC Marijuana (DRUG), High Dose THC Marijuana (DRUG), Placebo Marijuana (DRUG).
Who is sponsoring clinical trial NCT03191084?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.